Equity Profile
Post-Earnings Recap
Essent Group Ltd.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.52 | $0.41 | +54.76% |
| Revenue | — | $117M | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Liquidia Corporation is a pharmaceutical company focused on developing innovative treatments for patients with serious diseases. With a market cap of $4 billion, it operates in the health care sector, addressing significant medical needs through its proprietary technologies.
EPS
Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
Revenue figures will provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
$6.0M
Net selling
$404,401.77
Net selling
$525,362.04
Net selling
Recent Transactions
Apr 9, 2026 · @ $40.24
133,789 sh
$5.4M
Apr 15, 2026 · @ $40.14
86,971 sh
$3.5M
Apr 15, 2026 · @ $40.14
43,375 sh
$1.7M
Apr 13, 2026 · @ $38.37
32,744 sh
$1.3M
Apr 16, 2026 · @ $40.31
25,000 sh
$1.0M
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.